Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 23;60(4):576-583.
doi: 10.1515/cclm-2021-0306. Print 2022 Mar 28.

Biological variation of cardiac myosin-binding protein C in healthy individuals

Affiliations
Free article

Biological variation of cardiac myosin-binding protein C in healthy individuals

Bashir Alaour et al. Clin Chem Lab Med. .
Free article

Abstract

Objectives: Cardiac myosin-binding protein C (cMyC) is a novel biomarker of myocardial injury, with a promising role in the triage and risk stratification of patients presenting with acute cardiac disease. In this study, we assess the weekly biological variation of cMyC, to examine its potential in monitoring chronic myocardial injury, and to suggest analytical quality specification for routine use of the test in clinical practice.

Methods: Thirty healthy volunteers were included. Non-fasting samples were obtained once a week for ten consecutive weeks. Samples were tested in duplicate on the Erenna® platform by EMD Millipore Corporation. Outlying measurements and subjects were identified and excluded systematically, and homogeneity of analytical and within-subject variances was achieved before calculating the biological variability (CVI and CVG), reference change values (RCV) and index of individuality (II).

Results: Mean age was 38 (range, 21-64) years, and 16 participants were women (53%). The biological variation, RCV and II with 95% confidence interval (CI) were: CVA (%) 19.5 (17.8-21.6), CVI (%) 17.8 (14.8-21.0), CVG (%) 66.9 (50.4-109.9), RCV (%) 106.7 (96.6-120.1)/-51.6 (-54.6 to -49.1) and II 0.42 (0.29-0.56). There was a trend for women to have lower CVG. The calculated RCVs were comparable between genders.

Conclusions: cMyC exhibits acceptable RCV and low II suggesting that it could be suitable for disease monitoring, risk stratification and prognostication if measured serially. Analytical quality specifications based on biological variation are similar to those for cardiac troponin and should be achievable at clinically relevant concentrations.

Keywords: biological variation; cardiac myosin-binding protein C; index of individuality; reference change value.

PubMed Disclaimer

References

    1. Jacquet, S, Yin, X, Sicard, P, Clark, J, Kanaganayagam, GS, Mayr, M, et al.. Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis. Mol Cell Proteomics 2009;8:2687–99. https://doi.org/10.1074/mcp.m900176-mcp200.
    1. Marjot, J, Kaier, TE, Martin, ED, Reji, SS, Copeland, O, Iqbal, M, et al.. Quantifying the release of biomarkers of myocardial necrosis from cardiac myocytes and intact myocardium. Clin Chem 2017;63:990–6. https://doi.org/10.1373/clinchem.2016.264648.
    1. Baker, JO, Tyther, R, Liebetrau, C, Clark, J, Howarth, R, Patterson, T, et al.. Cardiac myosin-binding protein C: a potential early biomarker of myocardial injury. Basic Res Cardiol 2015;110:23. https://doi.org/10.1007/s00395-015-0478-5.
    1. Kaier, TE, Anand, A, Shah, AS, Mills, NL, Marber, M. Temporal relationship between cardiac myosin-binding protein C and cardiac troponin I in type 1 myocardial infarction. Clin Chem 2016;62:1153–5. https://doi.org/10.1373/clinchem.2016.257188.
    1. Schulte, C, Barwari, T, Joshi, A, Theofilatos, K, Zampetaki, A, Barallobre-Barreiro, J, et al.. Comparative analysis of circulating noncoding RNAs versus protein biomarkers in the detection of myocardial injury. Circ Res 2019;125:328–40. https://doi.org/10.1161/circresaha.119.314937.

Publication types

LinkOut - more resources